Nanogen buoyed by EU patent for stroke diagnostic
This article was originally published in Clinica
Nanogen saw its share price rise over 20% this week after announcing that its SynX Pharma subsidiary had gained a European patent covering a kit and method for diagnosing and distinguishing stroke.
You may also be interested in...
Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.
Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.
At the OurCrowd Global Investor Summit in Jerusalem, Israel, on 13 February, Medtech Insight met wound care device company Nanomedic to find out more about its unique electro-spinning technology.